CB vs FENC · P/E 14, rev $59.40B vs rev $17.9M
Chubb Ltd (CB) versus Fennec Pharmaceuticals Inc (FENC) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported FENC revenue for 2026-06-30 was $17.9M. Net income was $2.0M. Revenue was up 18.3% from 2026-03-31 to 2026-06-30. FENC currently screens at market cap $302.2M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. FENC currently screens at market cap $302.2M.
Not investment advice. Open the CB and FENC stock pages for the full models.
Not investment advice.